Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141032 · ClinicalTrials.gov registry record
Pathfinder Registry
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 109
- Enrollment target
NCT05141032: Completed study, sponsored by Baylor College of Medicine.
NCT05141032 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141032 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
This study collects information regarding your procedure. No changes will be done to your procedure and you are asked to consent for the use of your data in our database. You are being asked to be in this research study because you have a gastrointestinal lesion that needs to be removed. We remove these lesions endoscopically as part of the standard of care at Baylor St. Luke Medical Center, and we will be using a FDA approved device known as the Pathfinder Rigidization Overtube to assist with the removal of the polyp. This study is important because this is a relatively new procedure; although it is a part of your standard of care it is not done in many hospitals. We would like to document the outcomes and results of such procedures to continuously improve our standard of care.
Primary Outcome
Defined by the completion of endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) procedure while utilizing the Rigidization Overtube.
Interventions
- PROCEDURE Endoscopic Submucosal Dissection with Pathfinder/Overtube device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2023-11-01 |
What the finished NCT05141032 record still lists
NCT05141032 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic Submucosal Dissection with Pathfinder/Overtube device is the first listed.
NCT05141032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05141032 about?
NCT05141032 is a clinical study titled "Pathfinder Registry". This study collects information regarding your procedure. No changes will be done to your procedure and you are asked to consent for the use of your data in our database. You are being asked to be in this research study because you have a gastrointestinal lesion that needs to be removed. We remove t...
What is the current status of trial NCT05141032?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2021-10-18. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT05141032?
The interventions under investigation include: Endoscopic Submucosal Dissection with Pathfinder/Overtube device (PROCEDURE).
Who is sponsoring clinical trial NCT05141032?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI